A systematic review: the appraisal of the effects of metformin on lipoprotein modification and function
Summary Aims Metformin is a commonly prescribed anti‐hyperglycaemic pharmacological agent, and it remains a staple in the management of type II diabetes. In addition to metformin's glucose lowering effects, research has indicated that metformin inhibits glycation‐mediated and oxidative modifica...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-02-01
|
Series: | Obesity Science & Practice |
Subjects: | |
Online Access: | https://doi.org/10.1002/osp4.309 |